Back
Oxford Square Capital Vs. Novo Nordisk AS Industry Stock Comparison
Sell
27
OXSQ
Oxford Square Capital
Last Price:
$2.48
Seasonality Move:
-0.66%
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$87.86
Seasonality Move:
6.72%
Sell
27
Oxford Square Capital (OXSQ)
is a Sell
Is Oxford Square Capital a Buy, Sell or Hold?
-
The current Oxford Square Capital [OXSQ] share price is $2.48. The Score for OXSQ is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
OXSQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.86. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
OXSQ Stock Price Chart
What is Oxford Square Capital's stock price today?
-
The Oxford Square Capital share price today is $2.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OXSQ is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.86Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
OXSQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 26.67 | Sell |
Chaikin Money Flow: | -147931 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 2.7) | Sell |
Bollinger Bands (100): | (2.7 - 2.98) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 29.63 | Sell |
Chaikin Money Flow: | -16178 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.97 - 111.89) | Sell |
Bollinger Bands (100): | (106.42 - 130.98) | Sell |
OXSQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.56 | Sell |
20-day SMA: | 2.62 | Sell |
50-day SMA: | 2.76 | Sell |
200-day SMA: | 2.96 | Sell |
8-day EMA: | 2.54 | Sell |
20-day EMA: | 2.61 | Sell |
50-day EMA: | 2.71 | Sell |
200-day EMA: | 2.9 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.02 | Sell |
20-day SMA: | 106 | Sell |
50-day SMA: | 108.66 | Sell |
200-day SMA: | 125.92 | Sell |
8-day EMA: | 98.92 | Sell |
20-day EMA: | 103.95 | Sell |
50-day EMA: | 109.19 | Sell |
200-day EMA: | 117.71 | Sell |
Oxford Square Capital Earnings Growth & OXSQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.17 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Oxford Square Capital Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |